GeneReach Biotechnology Corp. (4171.TWO)
TWD 27.15
(1.69%)
TWD 27.15
(1.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 225.46 Million | 750.01 Million | 1.01 Billion | 857.03 Million | 365.79 Million |
| Cost of Revenue | 197.87 Million | 259.94 Million | 265.09 Million | 221.58 Million | 63.75 Million |
| Gross Profit | 27.58 Million | 490.07 Million | 746.98 Million | 635.44 Million | 302.04 Million |
| Operating Expenses | 256.86 Million | 249.86 Million | 259.57 Million | 278.04 Million | 190.1 Million |
| Selling, General and Administrative Expenses | 195.41 Million | 191.05 Million | 202.96 Million | 209.26 Million | 149.14 Million |
| Research and Development Expenses | 61.45 Million | 58.8 Million | 56.6 Million | 68.78 Million | 40.95 Million |
| Other Expenses | - | 35.35 Million | -7.1 Million | -12.98 Million | - |
| Cost and Expenses | 454.74 Million | 509.8 Million | 524.66 Million | 499.63 Million | 253.85 Million |
| Operating Income | -229.28 Million | 277.85 Million | 480.69 Million | 344.75 Million | 111.94 Million |
| Interest Expense | 5.76 Million | 6.61 Million | 6.26 Million | 3.81 Million | 4.13 Million |
| Income Tax Expense | -47.99 Million | 54.88 Million | 98.89 Million | 75.2 Million | 11.84 Million |
| Earnings before Tax | -218.34 Million | 272.37 Million | 469.37 Million | 338.94 Million | 105.49 Million |
| Net Income | -166.27 Million | 221.33 Million | 376.62 Million | 257.28 Million | 77.18 Million |
| Earnings Per Share Basic | -2.89 | 3.85 | 6.55 | 4.48 | 1.41 |
| Earnings Per Share Diluted | -2.89 | 3.77 | 6.45 | 4.47 | 1.37 |
| Weighted Average Shares Outstanding | 57.45 Million | 57.45 Million | 57.45 Million | 57.45 Million | 56.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.45 Million | 59.28 Million | 58.62 Million | 57.54 Million | 57.45 Million |
| Gross Margin | 0.12 | 0.65 | 0.74 | 0.74 | 0.83 |
| EBIT Margin | -0.64 | 0.46 | 0.53 | 0.46 | 0.36 |
| Profit Margin | -0.74 | 0.30 | 0.37 | 0.30 | 0.21 |
| EBITDA | -143.69 Million | 343.02 Million | 540.7 Million | 396.58 Million | 132.98 Million |
| Earnings Before Tax Margin | -1.02 | 0.37 | 0.47 | 0.40 | 0.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 43.15 Million | 45.9 Million | 54.82 Million | 225.46 Million | 48.18 Million | 54.26 Million |
| Cost of Revenue | 17.81 Million | 25.43 Million | 70.21 Million | 197.87 Million | 28.5 Million | 51.14 Million |
| Gross Profit | 25.34 Million | 20.46 Million | -15.39 Million | 27.58 Million | 19.68 Million | 3.12 Million |
| Operating Expenses | 58.48 Million | 69.03 Million | 60.2 Million | 235.43 Million | 60.53 Million | 59.65 Million |
| Selling, General and Administrative Expenses | 40.23 Million | 43.85 Million | 42.76 Million | - | 44.45 Million | 43.43 Million |
| Research and Development Expenses | 18.24 Million | 25.18 Million | 17.44 Million | - | 16.07 Million | 16.22 Million |
| Other Expenses | -6.99 Million | 20.53 Million | -19.12 Million | 2.23 Million | 13.75 Million | 9.05 Million |
| Cost and Expenses | 76.29 Million | 94.47 Million | 130.41 Million | 433.31 Million | 89.03 Million | 110.79 Million |
| Operating Income | -34.21 Million | -23.58 Million | -90.66 Million | -191.15 Million | -22.13 Million | -42.28 Million |
| Interest Expense | 1.39 Million | 1.16 Million | 1.27 Million | 5.76 Million | 1.23 Million | 1.67 Million |
| Income Tax Expense | -1.05 Million | -1.26 Million | -47.99 Million | -47.99 Million | -1.14 Million | -1.14 Million |
| Earnings before Tax | -37.24 Million | -21.52 Million | -107.24 Million | -218.34 Million | -25.87 Million | -47.15 Million |
| Net Income | -36.18 Million | -20.26 Million | -58.21 Million | -166.27 Million | -24.73 Million | -46.01 Million |
| Earnings Per Share Basic | -0.63 | -0.35 | -1.01 | - | -0.43 | -0.64 |
| Earnings Per Share Diluted | -0.63 | -0.35 | -1.01 | - | -0.43 | -0.64 |
| Weighted Average Shares Outstanding | 57.43 Million | 57.88 Million | 57.67 Million | 57.45 Million | 57.52 Million | 71.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.43 Million | 57.88 Million | 57.67 Million | 57.45 Million | 57.52 Million | 71.89 Million |
| Gross Margin | 0.59 | 0.45 | -0.28 | 0.12 | 0.41 | 0.06 |
| EBIT Margin | -0.35 | -0.10 | -1.33 | - | -0.10 | -0.47 |
| Profit Margin | -0.84 | -0.44 | -1.06 | -0.74 | -0.51 | -0.85 |
| EBITDA | -15.13 Million | -4.74 Million | -72.68 Million | - | -4.64 Million | -25.54 Million |
| Earnings Before Tax Margin | -0.79 | -0.51 | -1.65 | -0.85 | -0.46 | -0.78 |
CTPL5
FRCOY
PHSC
AMPE
7388
COTY